Notably, cells with NFKBIZ mutations are almost never found in colon cancers, and mice with NFKBIZ genetic disruption are resistant to the induction of colon adenocarcinomas [53], indicating that such expansions impede carcinogenesis. This evidence concerns the gene NFKBIZ and colonic neoplasm.